Search This Blog

Thursday, August 13, 2026

Wolfe Research upgrades Abbott Laboratories to Outperform with $130 price target

 


  • Firm cites stronger 2027 growth drivers, including electrophysiology and Libre CGM catalysts, for the rating upgrade.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)